Oric Pharmaceuticals Inc. (ORIC) Social Stream
Oric Pharmaceuticals Inc (ORIC) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Oric Pharmaceuticals Inc.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 13 months, ORIC's average price target has gone down $18.14.
Over the past 47 weeks, ORIC's average upside potential has been 205.07%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
ORIC Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 39 weeks, ORIC's average broker recommendation rating worsened by 0.57.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ORIC as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, Oric Pharmaceuticals Inc's upside potential (average analyst target price relative to current price) is higher than 549.2% of them.
- ORIC has a lower variance in analysts' estimates than -386.61% of all US stocks.
- In the context of stocks in the small market cap category, Oric Pharmaceuticals Inc's number of analysts covering the stock is higher than 492.81% of them.
- In the context of stocks in the small market cap category, Oric Pharmaceuticals Inc's average analyst price target is greater than 379.65% of them.
In the Pharmaceutical Products industry, OPTN, ONTX, and ONCY are the three stocks most similar to Oric Pharmaceuticals Inc regarding the price target and analyst recommendation information presented here.
Is ORIC a Buy, Hold or Sell? See the POWR Ratings now!